301207 华兰疫苗
已收盘 05-09 15:00:00
资讯
新帖
简况
华兰疫苗(301207)2025年一季报简析:净利润减15.06%
证券之星 · 04-28
华兰疫苗(301207)2025年一季报简析:净利润减15.06%
华兰疫苗(301207.SZ)发布一季度业绩,归母净利润3277.71万元,同比下降15.06%
智通财经 · 04-27
华兰疫苗(301207.SZ)发布一季度业绩,归母净利润3277.71万元,同比下降15.06%
华兰疫苗最新公告:继续使用不超过10亿元闲置募集资金进行现金管理
证券之星 · 02-28
华兰疫苗最新公告:继续使用不超过10亿元闲置募集资金进行现金管理
华兰疫苗:公司目前拥有6个流感疫苗原液生产车间,具备年产一亿剂四价流感疫苗的产能
证券之星 · 01-27
华兰疫苗:公司目前拥有6个流感疫苗原液生产车间,具备年产一亿剂四价流感疫苗的产能
价格战持续,国内流感疫苗赛道要卷到何时?
第一财经 · 01-26
价格战持续,国内流感疫苗赛道要卷到何时?
一周复盘 | 华兰疫苗本周累计上涨0.35%,生物制品板块下跌0.29%
金融界 · 01-26
一周复盘 | 华兰疫苗本周累计上涨0.35%,生物制品板块下跌0.29%
破发股华兰疫苗去年业绩预降 2022上市见顶募22.76亿
中国经济网 · 01-19
破发股华兰疫苗去年业绩预降 2022上市见顶募22.76亿
华兰疫苗最新公告:2024年度净利润预计同比下降70.93%-76.74%
证券之星 · 01-16
华兰疫苗最新公告:2024年度净利润预计同比下降70.93%-76.74%
华兰疫苗:预计2024年全年归属净利润盈利2亿元至2.5亿元
证券之星 · 01-16
华兰疫苗:预计2024年全年归属净利润盈利2亿元至2.5亿元
华兰疫苗(301207.SZ)发预减,预计2024年度净利润2亿元至2.5亿元 下降70.93%至76.74%
智通财经 · 01-16
华兰疫苗(301207.SZ)发预减,预计2024年度净利润2亿元至2.5亿元 下降70.93%至76.74%
华兰疫苗(301207.SZ)财务总监吕成玉辞职
智通财经 · 01-10
华兰疫苗(301207.SZ)财务总监吕成玉辞职
华兰疫苗(301207)1月7日主力资金净卖出259.44万元
证券之星 · 01-08
华兰疫苗(301207)1月7日主力资金净卖出259.44万元
华兰疫苗跌3.79% 2022年上市即巅峰募22.76亿
中国经济网 · 01-07
华兰疫苗跌3.79% 2022年上市即巅峰募22.76亿
华兰疫苗下跌5.09%,报17.54元/股
金融界 · 01-07
华兰疫苗下跌5.09%,报17.54元/股
流感高发季来临,甲流概念股多股涨停!上市公司回应
21世纪经济报道 · 01-06
流感高发季来临,甲流概念股多股涨停!上市公司回应
华兰疫苗涨5.57%,国金证券二个月前给出“买入”评级
证券之星 · 2024-11-04
华兰疫苗涨5.57%,国金证券二个月前给出“买入”评级
华兰疫苗(301207)2024年三季报简析:净利润减57.54%,三费占比上升明显
证券之星 · 2024-10-30
华兰疫苗(301207)2024年三季报简析:净利润减57.54%,三费占比上升明显
华兰疫苗(301207)9月30日股东户数1.72万户,较上期减少0.46%
证券之星 · 2024-10-30
华兰疫苗(301207)9月30日股东户数1.72万户,较上期减少0.46%
加载更多
公司概况
公司名称:
华兰生物疫苗股份有限公司
所属行业:
医药制造业
上市日期:
2022-02-18
主营业务:
华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感疫苗。
发行价格:
56.88
{"stockData":{"symbol":"301207","market":"SZ","secType":"STK","nameCN":"华兰疫苗","latestPrice":16.14,"timestamp":1746774225000,"preClose":16.23,"halted":0,"volume":1168201,"delay":0,"changeRate":-0.0055,"floatShares":142000000,"shares":601000000,"eps":0.3323,"marketStatus":"已收盘","change":-0.09,"latestTime":"05-09 15:00:00","open":16.36,"high":16.36,"low":16.1,"amount":18904100,"amplitude":0.016,"askPrice":16.15,"askSize":3,"bidPrice":16.14,"bidSize":74,"shortable":0,"etf":0,"ttmEps":0.3323,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.23,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":17.85,"lowLimit":14.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":601027500,"isCdr":false,"pbRate":1.61,"roa":"--","peRate":48.570569,"roe":"0.54%","epsLYR":0.3436,"committee":0.543478,"marketValue":9701000000,"turnoverRate":0.0082,"status":1,"floatMarketCap":2286000000},"requestUrl":"/m/hq/s/301207","defaultTab":"news","newsList":[{"id":"2531692298","title":"华兰疫苗(301207)2025年一季报简析:净利润减15.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531692298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531692298?lang=zh_cn&edition=full","pubTime":"2025-04-29 06:20","pubTimestamp":1745878820,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华兰疫苗发布2025年一季报。根据财报显示,华兰疫苗净利润减15.06%。2024 年度,公司实现营业收入 11.28 亿元,较上年下降 53.21%;归属于上市公司股东的净利润 2.06 亿元,较上年下降 76.10%。2025 年第一季度,公司实现营业收入 2,428.25 万元,同比下滑29.05%,实现归母净利润 3,277.71 万元,同比下滑 15.06%,实现扣非后净利润 1,541.58 万元,同比增长 8.89%。公司 2025 年第一季度实现的净利润量在同行业上市公司中排名居前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900006897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2530431638","title":"华兰疫苗(301207.SZ)发布一季度业绩,归母净利润3277.71万元,同比下降15.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530431638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530431638?lang=zh_cn&edition=full","pubTime":"2025-04-27 18:55","pubTimestamp":1745751318,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华兰疫苗(301207.SZ)发布2025年第一季度报告,公司一季度营业收入2428.25万元,同比下降29.05%;归属于上市公司股东的净利润3277.71万元,同比下降15.06%;归属于上市公司股东的扣除非经常性损益的净利润1541.58万元,同比增长8.89%;基本每股收益0.0551元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207"],"gpt_icon":0},{"id":"2514349380","title":"华兰疫苗最新公告:继续使用不超过10亿元闲置募集资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2514349380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514349380?lang=zh_cn&edition=full","pubTime":"2025-02-28 17:50","pubTimestamp":1740736247,"startTime":"0","endTime":"0","summary":"华兰疫苗(301207.SZ)公告称,拟继续使用不超过10亿元闲置募集资金进行现金管理。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800032331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2506342799","title":"华兰疫苗:公司目前拥有6个流感疫苗原液生产车间,具备年产一亿剂四价流感疫苗的产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2506342799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506342799?lang=zh_cn&edition=full","pubTime":"2025-01-27 15:30","pubTimestamp":1737963021,"startTime":"0","endTime":"0","summary":"是否有新的产能规划华兰疫苗董秘:尊敬的投资者您好,公司目前拥有6个流感疫苗原液生产车间,具备年产一亿剂四价流感疫苗的产能,目前流感疫苗暂无新的产能建设规划,感谢您对公司的关注。谢谢华兰疫苗董秘:尊敬的投资者您好,公司依照会计准则的相关规定,于每年年末对尚未销售的流感疫苗全额计提存货跌价准备,上述事项影响了公司第四季度的业绩,感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700014257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2506331336","title":"价格战持续,国内流感疫苗赛道要卷到何时?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506331336","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506331336?lang=zh_cn&edition=full","pubTime":"2025-01-26 15:22","pubTimestamp":1737876124,"startTime":"0","endTime":"0","summary":"统计显示,国内在流感疫苗领域布局的企业和获批产品正在不断增多。截至目前,国内共有16家企业拥有流感疫苗批文,已上市流感疫苗产品19种,分别较2020年时新增6家公司和5款产品。可以预期,随着上市产品不断增多,若国内流感疫苗接种率不能继续增长,行业竞争势必日趋白热化。该负责人还表示,为进一步缩短生产周期,金迪克流感疫苗新车间项目正新建多条原液生产线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://tech.ifeng.com/c/8gSQDFDeqmi","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8gSQDFDeqmi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["688670","06660","BK1161","301207","688185","BK0239"],"gpt_icon":0},{"id":"2506384614","title":"一周复盘 | 华兰疫苗本周累计上涨0.35%,生物制品板块下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506384614","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506384614?lang=zh_cn&edition=full","pubTime":"2025-01-26 10:55","pubTimestamp":1737860136,"startTime":"0","endTime":"0","summary":"1月20日至1月24日本周创业板指上涨2.64%,生物制品板块下跌0.29%。华兰疫苗本周累计上涨0.35%,周总成交额2.86亿元,截至本周收盘,华兰疫苗股价为17.03元。代码名称最新价周涨跌幅10日涨跌幅月涨跌幅300122智飞生物24.31元-2.21%0.37%-7.57%688253英诺特29.50元-10.71%-15.47%-18.64%002693双成药业13.31元-16.50%-12.43%-27.39%688235百济神州-U189.00元3.74%17.65%17.38%600161天坛生物20.72元6.75%8.6%1.07%","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/26105547829391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2504451566","title":"破发股华兰疫苗去年业绩预降 2022上市见顶募22.76亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2504451566","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504451566?lang=zh_cn&edition=full","pubTime":"2025-01-19 15:31","pubTimestamp":1737271860,"startTime":"0","endTime":"0","summary":" 华兰疫苗于2022年2月18日在深交所创业板上市,公开发行的股票数量为4001.00万股,发行价格为56.88元/股,保荐机构为华泰联合证券有限责任公司,保荐代表人为贾鹏、刘晓宁。 上市首日,华兰疫苗盘中创下上市以来最高点79.78元,随后该股震荡下跌。 华兰疫苗首次公开发行股票募集资金总额为22.76亿元,扣除含税发行费用3156.57万元,实际募集资金净额为22.44亿元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-01-19/doc-inefnxky1275333.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-19/doc-inefnxky1275333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2503952425","title":"华兰疫苗最新公告:2024年度净利润预计同比下降70.93%-76.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503952425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503952425?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:48","pubTimestamp":1737017319,"startTime":"0","endTime":"0","summary":"华兰疫苗公告,预计2024年度归属于上市公司股东的净利润盈利2亿元–2.5亿元,比上年同期下降76.74%-70.93%。同时,公司保持对创新型疫苗、基因工程疫苗等技术平台的研发投入,研发费用保持较高投入,对净利润产生不利影响。预计非经常性损益对净利润的影响金额约为9000万元,主要系公司利用闲置资金投资产生的理财收益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011600026733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2503548659","title":"华兰疫苗:预计2024年全年归属净利润盈利2亿元至2.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503548659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503548659?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:15","pubTimestamp":1737015326,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗发布业绩预告,预计2024年全年归属净利润盈利2亿元至2.5亿元。华兰疫苗2024年三季报显示,公司主营收入9.57亿元,同比下降44.28%;归母净利润2.67亿元,同比下降57.54%;扣非净利润1.96亿元,同比下降64.65%;其中2024年第三季度,公司单季度主营收入9.22亿元,同比下降41.23%;单季度归母净利润2.42亿元,同比下降53.58%;单季度扣非净利润2.17亿元,同比下降56.24%;负债率20.25%,投资收益5581.3万元,财务费用-766.08万元,毛利率81.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011600025749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2503595916","title":"华兰疫苗(301207.SZ)发预减,预计2024年度净利润2亿元至2.5亿元 下降70.93%至76.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503595916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503595916?lang=zh_cn&edition=full","pubTime":"2025-01-16 16:00","pubTimestamp":1737014454,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华兰疫苗 发布2024年度业绩预告,预计2024年度归属于上市公司股东的净利润2亿元至2.5亿元,同比下降70.93%至76.74%。2024年度,公司预计非经常性损益对净利润的影响金额约为9000万元,主要系公司利用闲置资金投资产生的理财收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1238589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207"],"gpt_icon":0},{"id":"2502835563","title":"华兰疫苗(301207.SZ)财务总监吕成玉辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2502835563","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502835563?lang=zh_cn&edition=full","pubTime":"2025-01-10 16:04","pubTimestamp":1736496259,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华兰疫苗(301207.SZ)公告,公司董事会于近日收到公司董事会秘书兼财务总监吕成玉先生提交的书面辞职报告,吕成玉先生因个人原因辞去公司董事会秘书及财务总监职务,辞职后不再担任公司及子公司的任何职务。吕成玉先生的辞职报告自送达公司董事会之日起生效。公司董事会同意在聘任新的董事会秘书及财务总监前,指定董事兼总经理安文珏女士代行董事会秘书及财务总监职责。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1235959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2501766861","title":"华兰疫苗(301207)1月7日主力资金净卖出259.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501766861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501766861?lang=zh_cn&edition=full","pubTime":"2025-01-08 09:19","pubTimestamp":1736299165,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年1月7日收盘,华兰疫苗报收于17.78元,下跌3.79%,换手率5.08%,成交量7.2万手,成交额1.28亿元。近5日资金流向一览见下表:华兰疫苗融资融券信息显示,融资方面,当日融资买入1633.78万元,融资偿还1171.66万元,融资净买入462.13万元。华兰疫苗主营业务:人用疫苗的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800008091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2501278635","title":"华兰疫苗跌3.79% 2022年上市即巅峰募22.76亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2501278635","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501278635?lang=zh_cn&edition=full","pubTime":"2025-01-07 16:26","pubTimestamp":1736238360,"startTime":"0","endTime":"0","summary":" 华兰疫苗于2022年2月18日在深交所创业板上市,公开发行的股票数量为4001.00万股,发行价格为56.88元/股,保荐机构为华泰联合证券有限责任公司,保荐代表人为贾鹏、刘晓宁。 上市首日,华兰疫苗盘中创下上市以来最高点79.78元,随后该股震荡下跌。 华兰疫苗首次公开发行股票的发行费用总额为3156.57万元,其中,华泰联合证券有限责任公司获得承销费用、保荐费用合计2200.00万元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-01-07/doc-ineecwet2028375.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-07/doc-ineecwet2028375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2501021047","title":"华兰疫苗下跌5.09%,报17.54元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2501021047","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501021047?lang=zh_cn&edition=full","pubTime":"2025-01-07 11:27","pubTimestamp":1736220444,"startTime":"0","endTime":"0","summary":"1月7日,华兰疫苗盘中下跌5.09%,截至11:27,报17.54元/股,成交9311.12万元,换手率3.69%,总市值105.42亿元。截至9月30日,华兰疫苗股东户数1.72万,人均流通股8246股。2024年1月-9月,华兰疫苗实现营业收入9.57亿元,同比减少44.28%;归属净利润2.67亿元,同比减少57.54%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/07112747193463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2501471016","title":"流感高发季来临,甲流概念股多股涨停!上市公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2501471016","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501471016?lang=zh_cn&edition=full","pubTime":"2025-01-06 11:28","pubTimestamp":1736134080,"startTime":"0","endTime":"0","summary":" 消息面上,据央视新闻报道,近期,流感高发,据中国疾控中心最新数据,目前流感病毒阳性率持续上升,其中99%以上为甲流。据了解,甲型流感,简称“甲流”,是由甲型流感病毒引起的急性呼吸道传染病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-01-06/doc-ineczaiz3231435.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-06/doc-ineczaiz3231435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0102","300723","BK0188","000597","600721","BK0028","BK0191","BK0060","600789","600812","300158","300147","BK0012","BK0239","300434","002317","BK0114","BK0077","BK0070","BK0216","600664","600380","300039","BK0168","BK0046","301207","BK0186"],"gpt_icon":0},{"id":"2480375545","title":"华兰疫苗涨5.57%,国金证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480375545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480375545?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:23","pubTimestamp":1730708622,"startTime":"0","endTime":"0","summary":"今日华兰疫苗涨5.57%,收盘报19.71元。2024年8月30日,国金证券研究员袁维发布了对华兰疫苗的研报《签发批次持续领先,静待流感疫苗放量》,该研报对华兰疫苗给出“买入”评级。2023-2025年公司对应EPS分别为0.98、1.22、1.46元,对应当前PE分别为18、15、12倍。维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的朱言音。华兰疫苗个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400020299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2479879816","title":"华兰疫苗(301207)2024年三季报简析:净利润减57.54%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2479879816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479879816?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:46","pubTimestamp":1730328388,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华兰疫苗发布2024年三季报。截至本报告期末,公司营业总收入9.57亿元,同比下降44.28%,归母净利润2.67亿元,同比下降57.54%。按单季度数据看,第三季度营业总收入9.22亿元,同比下降41.23%,第三季度归母净利润2.42亿元,同比下降53.58%。本报告期华兰疫苗三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达101.26%。去年的净利率为35.68%,算上全部成本后,公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2479278143","title":"华兰疫苗(301207)9月30日股东户数1.72万户,较上期减少0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479278143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479278143?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:29","pubTimestamp":1730280595,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华兰疫苗披露,截至2024年9月30日公司股东户数为1.72万户,较6月30日减少79.0户,减幅为0.46%。在生物制品行业个股中,华兰疫苗股东户数低于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.36万户。从股价来看,2024年6月30日至2024年9月30日,华兰疫苗区间涨幅为17.6%,在此期间股东户数减少79.0户,减幅为0.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000033852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746902312131,"stockEarnings":[{"period":"1week","weight":0.0209},{"period":"1month","weight":0.0235},{"period":"3month","weight":-0.1127},{"period":"6month","weight":-0.2154},{"period":"1year","weight":-0.2799},{"period":"ytd","weight":-0.0782}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物疫苗股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16924人(较上一季度减少2.49%)","perCapita":"8369股","listingDate":"2022-02-18","address":"河南省新乡市红旗区华兰大道甲1号附1号","registeredCapital":"60102万元","survey":" 华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感疫苗。","listedPrice":56.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰疫苗,301207,华兰疫苗股票,华兰疫苗股票老虎,华兰疫苗股票老虎国际,华兰疫苗行情,华兰疫苗股票行情,华兰疫苗股价,华兰疫苗股市,华兰疫苗股票价格,华兰疫苗股票交易,华兰疫苗股票购买,华兰疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}